Allan Toguri¹, Jack Barkin²

Canadian Journal of Urology, Vol.17, Suppl.1, pp. 26-34, 2010

Abstract The past decade has profoundly changed how physicians manage patients with benign prostatic hyperplasia (BPH). The concepts of symptom indices, symptom complexes, fl ow rates, prostate-specifi c antigen (PSA), prostate size and new medical approaches supported by new clinical studies, have provided family practitioners as well as specialists with evidence-based management algorithms to treat BPH. Men with BPH most often visit a physician due to their partner’s urging because of the many symptoms, with the most bothersome being nocturia. Today, primary care physicians are the gatekeepers for diagnosing and managing lower urinary tract symptoms (LUTS) More >

John S. Kell

Canadian Journal of Urology, Vol.17, Suppl.1, pp. 18-25, 2010

Abstract Prostate cancer is a highly prevalent malignancy. Using serum prostatic-specifi c antigen (PSA) levels to screen for prostate cancer has led to a greater detection of this cancer, at earlier stages. However, screening for prostate cancer by determining PSA levels remains controversial. Concerns include the risk of overdiagnosis and conversely, the failure to detect all prostate cancers. This article, aimed at primary care practitioners, reviews the characteristics of an ideal screening test, in relation to the characteristics of the PSA test. It then discusses the implications of recent fi ndings from two large, randomized, prospective More >

William A. Easton

Canadian Journal of Urology, Vol.17, Suppl.1, pp. 12-17, 2010

Abstract The symptoms of overactive bladder (OAB) -- urinary urgency, frequency, and urge incontinence -- can cause signifi cant lifestyle limitations. Social isolation, depression, employment diffi culties, and relationship stress are common fi ndings in patients with this condition. This article focuses on women with OAB who are seen in primary care. Occasionally, OAB (or detrusor overactivity) may be the result of neurological disease, metabolic disease, or urinary tract abnormalities. Primary care practitioners can play a key role in identifying affected individuals by including a focused question in every annual patient physical assessment. Investigation and treatment More >

Jack Barkin

Canadian Journal of Urology, Vol.17, Suppl.1, pp. 2-11, 2010

Abstract Studies have repeatedly confi rmed that about 52% of men between the ages of 40 and 70 years have some degree of erectile dysfunction (ED). Other studies have shown that as a man ages, his testosterone level will naturally decrease. Over the last number of years, we have also seen that ED may be one of the earliest signs and markers of endothelial dysfunction. There appears to be an overlap between ED, metabolic syndrome, and symptomatic late onset hypogonadism (SLOH).
It is very important for the primary care physician to identify patients who are suffering from More >

Jack Barkin

Canadian Journal of Urology, Vol.17, Suppl.1, pp. 1-1, 2010

Abstract This article has no abstract. More >

Mary J. Mackenzie, Eric Winquist, George Rodrigues

Canadian Journal of Urology, Vol.17, No.1, pp. 5050-5056, 2010

Abstract This article has no abstract. More >

Richard W. Casey¹, Jack Barkin²

Canadian Journal of Urology, Vol.17, No.1, pp. 5048-5049, 2010

Abstract This article has no abstract. More >

Dean E. Leocádio¹, Martin A. Koyle², Shamlal Mangray³, Anthony A. Caldamone⁴

Canadian Journal of Urology, Vol.17, No.1, pp. 5044-5047, 2010

Abstract Wilms’ tumor (WT) is the most common primary malignant renal tumor in children and usually presents as an abdominal mass. Rhabdomyomatous nephroblastoma is a rare histologic variant of WT. Herein we report an unusual case of WT with rhabdomyomatous differentiation presenting with hematuria and the passage of tissue via the urethra in a 2-year-old male. More >

Daniel Toguri¹, D. Andrew Loblaw², Robert K. Nam³

Canadian Journal of Urology, Vol.17, No.1, pp. 5040-5043, 2010

Abstract Introduction: Postoperative radiotherapy after radical prostatectomy has been shown to improve numerous outcomes for selected patients in mature randomized controlled trials. During treatment patients usually experience mild to moderate urinary symptoms, lower gastrointestinal symptoms and tiredness. We describe an unusual case of a patient experiencing severe, culture negative urinary symptoms early in a course of salvage radiotherapy.
Materials and methods: A patient's history was retrospectively derived from a single institution.
Results: A total radiation dosage of 66 Gy in 33 fractions was to be delivered to the prostate bed by intensity modulated radiation therapy. Urinary symptoms consisting of More >

Tahir Karadeniz, Caner Baran, Medih Topsakal

Canadian Journal of Urology, Vol.17, No.1, pp. 5038-5039, 2010

Abstract Aggressive fibromatosis or desmoid tumor is a histologically benign entity with unknown etiology that may present a serious clinical course. Due to its high tendency to recur and local aggressive behavior, and as there is no established effective medical treatment, complete surgical excision remains the sole management. To our knowledge, we describe the first case of giant desmoid tumor which arose from ileal neobladder mesenterium in a bladder cancer patient with orthotopic substitution. More >